Trial intelligence / Profile preview

Pilot Trial of Levetiracetam for Alcohol Dependence with Anxiety

NCT00141115Phase 2Completed

Sponsor
New York State Psychiatric Institute
Start
Mar 2004
Primary completion
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of levetiracetam in alcohol dependence, sponsored by New York State Psychiatric Institute. Primary endpoint: Participants Who Reported Reductions in Alcohol Consumption at 9 weeks. Started Mar 2004; status: completed.

02

Drugs

levetiracetam
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT00141115.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00141115.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call